This article discusses the potential of utilizing mRNA technology, which has been popularized during the COVID-19 pandemic, to create safe and effective vaccines for the influenza virus. Traditional influenza vaccines offer varying levels of immunity and have limitations due to their egg-based production. The use of mRNA technology can overcome the
27-27 April 2023